758 results on '"Carling, David"'
Search Results
2. Precise intracellular uptake and endosomal release of diverse functional mRNA payloads via glutathione-responsive nanogels
3. Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity
4. The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
5. Editorial Expression of Concern: Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
6. Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
7. AMPK activation protects against prostate cancer by inducing a catabolic cellular state
8. Opposing effects on regulated insulin secretion of acute vs chronic stimulation of AMP-activated protein kinase
9. IL11 stimulates ERK/P90RSK to inhibit LKB1/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells
10. Interleukin 11 therapy causes acute left ventricular dysfunction.
11. Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma
12. Direct small molecule ADaM-site AMPK activators reveal an AMPKγ3-independent mechanism for blood glucose lowering
13. Cell competition acts as a purifying selection to eliminate cells with mitochondrial defects during early mouse development
14. Chronic GIPR agonism results in pancreatic islet GIPR functional desensitisation
15. AMP-activated protein kinase activation suppresses leptin expression independently of adipogenesis in primary murine adipocytes
16. Dietary protein defends lean mass and maintains the metabolic benefits of glucagon receptor agonism in mice
17. Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly
18. Hematoma Resolution In Vivo Is Directed by Activating Transcription Factor 1 (ATF1)
19. A special issue of Essays in Biochemistry on AMPK and AMPK-related kinases.
20. AMP-activated protein kinase: the current landscape for drug development
21. AMPK activation protects against diet-induced obesity through Ucp1-independent thermogenesis in subcutaneous white adipose tissue
22. The synthesis and electronic structure of molybdenum ene-1,2-dithiolate complexes
23. Activation of Yeast Snf1 and Mammalian AMP-Activated Protein Kinase by Upstream Kinases
24. AMPK signalling in health and disease
25. Proposed Changes To Pharmaceutical Regulatory Exclusivities In Europe
26. Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function
27. Mutation of Fnip1 is associated with B-cell deficiency, cardiomyopathy, and elevated AMPK activity
28. Abstract 439: From foe to friend: In vivo reprogramming of tumor-associated macrophages to an anti-cancer phenotype by modulating N-myristoyltransferase activity
29. Supplementary Fig. S4 from CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis
30. Data from CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis
31. Supplementary Table 1 from CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis
32. Supplementary Figure 6 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
33. Supplementary Figure 9 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
34. Data from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
35. Supplementary Figure 1 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
36. Supplementary Figure 7 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
37. Supplementary Figure Legends from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
38. Supplementary Figure 4 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
39. Supplementary Figure 8 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
40. Supplementary Figure 2 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
41. Supplementary Figure 5 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
42. Supplementary Materials and Methods from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
43. Supplementary Figure 3 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
44. Beyond Energy Homeostasis: the Expanding Role of AMP-Activated Protein Kinase in Regulating Metabolism
45. AMPK hierarchy: a matter of space and time
46. Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss
47. Inhibiting lysosomal aldolase: a magic bullet for AMPK activation in treating metabolic disease?
48. Hepatocyte cholesterol content modulates glucagon receptor signalling
49. The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
50. Signaling Kinase AMPK Activates Stress-Promoted Transcription via Histone H2B Phosphorylation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.